NDC 14783-062

LBel Supremacie Mains

Ensulizole, Octinoxate, And Oxybenzone

LBel Supremacie Mains is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Ventura International Ltd.,. The primary component is Ensulizole; Octinoxate; Oxybenzone.

• Product ID: 14783-062_f9c27f44-9167-439a-a8bf-0280eabe477e
• NDC: 14783-062
• Product Type: Human Otc Drug
• Proprietary Name: LBel Supremacie Mains
• Generic Name: Ensulizole, Octinoxate, And Oxybenzone
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2010-08-15
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part352
• Labeler Name: VENTURA INTERNATIONAL LTD.,
• Substance Name: ENSULIZOLE; OCTINOXATE; OXYBENZONE
• Active Ingredient Strength: 0 g/5mL; g/5mL; g/5mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 14783-062-51

1 JAR in 1 BOX (14783-062-51) > 5 mL in 1 JAR (14783-062-52)

• Marketing Start Date: 2010-08-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 14783-062-52 [14783006252]

LBel Supremacie Mains CREAM

• Marketing Category: OTC MONOGRAPH FINAL
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2010-08-15

NDC 14783-062-51 [14783006251]

LBel Supremacie Mains CREAM

• Marketing Category: OTC MONOGRAPH FINAL
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2010-08-15
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ENSULIZOLE	.15 g/5mL

OpenFDA Data

• SPL SET ID: 2062a8d1-de1e-468c-9105-20aa01e1150f
• Manufacturer:
  • VENTURA INTERNATIONAL LTD.,
• UNII:
  • 95OOS7VE0Y
  • 4Y5P7MUD51
  • 9YQ9DI1W42

NDC Crossover Matching brand name "LBel Supremacie Mains" or generic name "Ensulizole, Octinoxate, And Oxybenzone"

NDC	Brand Name	Generic Name
14783-062	LBel	Ensulizole, Octinoxate, and Oxybenzone
14783-072	LBel	Ensulizole, Octinoxate, and Oxybenzone